Financial News

Faron Pharmaceuticals moving "into next phase" with new CFO

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief financial officer James O'Brien speaks to Proactive on his second day in the new role.

O'Brien reveals more about what he believes he can bring to Faron, highlighting his experience in the US capital markets.

He adds that Faron is now moving "into [its} next phase of growth."

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  253.60
-3.18 (-1.24%)
AAPL  334.42
+2.15 (0.65%)
AMD  495.94
-20.19 (-3.91%)
BAC  58.96
-3.73 (-5.95%)
GOOG  345.06
+9.61 (2.86%)
META  665.80
+17.77 (2.74%)
MSFT  507.35
+11.72 (2.36%)
NVDA  212.12
-6.17 (-2.83%)
ORCL  143.57
-6.71 (-4.46%)
TSLA  360.31
-5.13 (-1.40%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback